tiprankstipranks
Zura Bio Announces Phase 2 Tibulizumab Study
PremiumCompany AnnouncementsZura Bio Announces Phase 2 Tibulizumab Study
4M ago
Zura Bio submits protocol to FDA for Phase 2 study of Tibulizumab
Premium
The Fly
Zura Bio submits protocol to FDA for Phase 2 study of Tibulizumab
4M ago
Zura Bio price target raised to $12 from $11 at Chardan
Premium
The Fly
Zura Bio price target raised to $12 from $11 at Chardan
4M ago
Zura Bio management to meet with  Piper Sandler
PremiumThe FlyZura Bio management to meet with Piper Sandler
6M ago
Zura Bio Unveils Future Strategy and Biologic Pipeline Update
Premium
Company Announcements
Zura Bio Unveils Future Strategy and Biologic Pipeline Update
6M ago
Zura Bio initiated with a Neutral at H.C. Wainwright
Premium
The Fly
Zura Bio initiated with a Neutral at H.C. Wainwright
6M ago
Zura Bio reports Q2 EPS (17c), consensus (15c)
PremiumThe FlyZura Bio reports Q2 EPS (17c), consensus (15c)
7M ago
ZURA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ZURA Earnings this Week: How Will it Perform?
7M ago
Zura Bio Announces CEO Transition and Executive Compensation Details
Premium
Company Announcements
Zura Bio Announces CEO Transition and Executive Compensation Details
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100